Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Prostate CA

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongda Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (resident doctor) · 2978793353@qq.com · 中国+1885069821

Study leads

Vice President of Zhongda Hospital
Study Director
Zhongda Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nantong, China

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Prostate CA · Prostate Cancer (Adenocarcinoma) · Prostate Cancer Surgery

Abroad (travel likely)RecruitingPHASE1

Orlando, United States

Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Surrey, Canada · Victoria, Canada

Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study

Prostate CA

Abroad (travel likely)Recruiting

London, United Kingdom